34016733|t|Glitter in the Darkness? Nonfibrillar beta-Amyloid Plaque Components Significantly Impact the beta-Amyloid PET Signal in Mouse Models of Alzheimer Disease.
34016733|a|beta-amyloid (Abeta) PET is an important tool for quantification of amyloidosis in the brain of suspected Alzheimer disease (AD) patients and transgenic AD mouse models. Despite the excellent correlation of Abeta PET with gold standard immunohistochemical assessments, the relative contributions of fibrillar and nonfibrillar Abeta components to the in vivo Abeta PET signal remain unclear. Thus, we obtained 2 murine cerebral amyloidosis models that present with distinct Abeta plaque compositions and performed regression analysis between immunohistochemistry and Abeta PET to determine the biochemical contributions to Abeta PET signal in vivo. Methods: We investigated groups of AppNL-G-F and APPPS1 mice at 3, 6, and 12 mo of age by longitudinal 18F-florbetaben Abeta PET and with immunohistochemical analysis of the fibrillar and total Abeta burdens. We then applied group-level intermodality regression models using age- and genotype-matched sets of fibrillar and nonfibrillar Abeta data (predictors) and Abeta PET results (outcome) for both Abeta mouse models. An independent group of double-hit APPPS1 mice with dysfunctional microglia due to knockout of triggering receptor expression on myeloid cells 2 (Trem2-/-) served for validation and evaluation of translational impact. Results: Neither fibrillar nor nonfibrillar Abeta content alone sufficed to explain the Abeta PET findings in either AD model. However, a regression model compiling fibrillar and nonfibrillar Abeta together with the estimate of individual heterogeneity and age at scanning could explain a 93% of variance of the Abeta PET signal (P < 0.001). Fibrillar Abeta burden had a 16-fold higher contribution to the Abeta PET signal than nonfibrillar Abeta. However, given the relatively greater abundance of nonfibrillar Abeta, we estimate that nonfibrillar Abeta produced 79% +- 25% of the net in vivo Abeta PET signal in AppNL-G-F mice and 25% +- 12% in APPPS1 mice. Corresponding results in separate groups of APPPS1/Trem2-/- and APPPS1/Trem2+/+ mice validated the calculated regression factors and revealed that the altered fibrillarity due to Trem2 knockout impacts the Abeta PET signal. Conclusion: Taken together, the in vivo Abeta PET signal derives from the composite of fibrillar and nonfibrillar Abeta plaque components. Although fibrillar Abeta has inherently higher PET tracer binding, the greater abundance of nonfibrillar Abeta plaque in AD-model mice contributes importantly to the PET signal.
34016733	121	126	Mouse	Species	10090
34016733	137	154	Alzheimer Disease	Disease	MESH:D000544
34016733	170	175	Abeta	Gene	351
34016733	224	235	amyloidosis	Disease	MESH:D000686
34016733	262	279	Alzheimer disease	Disease	MESH:D000544
34016733	281	283	AD	Disease	MESH:D000544
34016733	285	293	patients	Species	9606
34016733	309	311	AD	Disease	MESH:D000544
34016733	312	317	mouse	Species	10090
34016733	363	368	Abeta	Gene	351
34016733	482	487	Abeta	Gene	11820
34016733	514	519	Abeta	Gene	11820
34016733	567	573	murine	Species	10090
34016733	574	594	cerebral amyloidosis	Disease	MESH:C538248
34016733	629	634	Abeta	Gene	11820
34016733	722	727	Abeta	Gene	11820
34016733	778	783	Abeta	Gene	11820
34016733	844	847	-G-	CellLine	CVCL:3572
34016733	860	864	mice	Species	10090
34016733	907	922	18F-florbetaben	Chemical	MESH:C527756
34016733	923	928	Abeta	Gene	11820
34016733	998	1003	Abeta	Gene	11820
34016733	1140	1145	Abeta	Gene	11820
34016733	1168	1173	Abeta	Gene	11820
34016733	1205	1210	Abeta	Gene	11820
34016733	1211	1216	mouse	Species	10090
34016733	1267	1271	mice	Species	10090
34016733	1371	1376	Trem2	Gene	83433
34016733	1487	1492	Abeta	Gene	11820
34016733	1531	1536	Abeta	Gene	11820
34016733	1560	1562	AD	Disease	MESH:D000544
34016733	1635	1640	Abeta	Gene	11820
34016733	1755	1760	Abeta	Gene	11820
34016733	1795	1800	Abeta	Gene	11820
34016733	1849	1854	Abeta	Gene	11820
34016733	1884	1889	Abeta	Gene	11820
34016733	1955	1960	Abeta	Gene	11820
34016733	1992	1997	Abeta	Gene	11820
34016733	2037	2042	Abeta	Gene	11820
34016733	2062	2066	-G-F	CellLine	CVCL:C4MU
34016733	2067	2071	mice	Species	10090
34016733	2097	2101	mice	Species	10090
34016733	2154	2159	Trem2	Gene	83433
34016733	2174	2179	Trem2	Gene	83433
34016733	2183	2187	mice	Species	10090
34016733	2282	2287	Trem2	Gene	83433
34016733	2309	2314	Abeta	Gene	11820
34016733	2367	2372	Abeta	Gene	11820
34016733	2441	2446	Abeta	Gene	11820
34016733	2485	2490	Abeta	Gene	11820
34016733	2571	2576	Abeta	Gene	11820
34016733	2587	2589	AD	Disease	MESH:D000544
34016733	2596	2600	mice	Species	10090
34016733	Association	MESH:D000544	351

